Nevro Net Receivables vs Total Assets Analysis

NVRO Stock  USD 4.52  0.16  3.67%   
Nevro Corp financial indicator trend analysis is infinitely more than just investigating Nevro Corp recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nevro Corp is a good investment. Please check the relationship between Nevro Corp Net Receivables and its Total Assets accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nevro Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.

Net Receivables vs Total Assets

Net Receivables vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nevro Corp Net Receivables account and Total Assets. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Nevro Corp's Net Receivables and Total Assets is 0.93. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Total Assets in the same time period over historical financial statements of Nevro Corp, assuming nothing else is changed. The correlation between historical values of Nevro Corp's Net Receivables and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Nevro Corp are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Net Receivables i.e., Nevro Corp's Net Receivables and Total Assets go up and down completely randomly.

Correlation Coefficient

0.93
Relationship DirectionPositive 
Relationship StrengthVery Strong

Net Receivables

Total Assets

Total assets refers to the total amount of Nevro Corp assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Nevro Corp books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from Nevro Corp's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nevro Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nevro Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.At this time, Nevro Corp's Sales General And Administrative To Revenue is very stable compared to the past year. As of the 22nd of November 2024, Enterprise Value is likely to grow to about 1.5 B, while Selling General Administrative is likely to drop about 215.3 M.
 2021 2022 2023 2024 (projected)
Gross Profit266.0M276.4M290.1M191.8M
Total Revenue386.9M406.4M425.2M280.2M

Nevro Corp fundamental ratios Correlations

0.910.860.970.420.870.86-0.860.890.680.630.60.610.970.930.920.940.910.910.910.870.960.980.71.00.92
0.910.670.830.420.90.77-0.860.840.70.690.810.520.790.980.870.920.710.970.950.930.930.940.740.890.86
0.860.670.810.290.710.9-0.640.640.380.440.410.840.920.70.640.680.930.630.610.660.750.860.520.870.65
0.970.830.810.410.790.76-0.80.910.710.560.510.560.970.860.950.930.910.830.880.780.930.910.630.980.95
0.420.420.290.410.570.38-0.520.590.030.280.210.150.40.390.380.420.450.420.380.130.510.410.360.410.39
0.870.90.710.790.570.73-0.910.810.660.690.670.530.790.850.770.820.720.880.790.850.930.890.780.840.76
0.860.770.90.760.380.73-0.660.610.260.470.520.770.870.810.640.690.910.770.680.710.750.90.540.860.64
-0.86-0.86-0.64-0.8-0.52-0.91-0.66-0.82-0.7-0.89-0.54-0.29-0.77-0.82-0.79-0.82-0.69-0.88-0.81-0.81-0.92-0.86-0.94-0.83-0.78
0.890.840.640.910.590.810.61-0.820.720.550.540.40.830.850.880.950.750.820.90.720.930.830.620.890.89
0.680.70.380.710.030.660.26-0.70.720.590.490.150.570.670.770.780.390.70.770.80.770.630.620.660.75
0.630.690.440.560.280.690.47-0.890.550.590.510.080.520.620.590.60.430.710.640.690.690.670.990.580.57
0.60.810.410.510.210.670.52-0.540.540.490.510.540.460.780.640.680.390.70.710.750.60.650.510.580.64
0.610.520.840.560.150.530.77-0.290.40.150.080.540.680.560.440.480.730.40.390.50.470.630.150.640.46
0.970.790.920.970.40.790.87-0.770.830.570.520.460.680.820.860.860.980.790.790.750.890.930.60.980.87
0.930.980.70.860.390.850.81-0.820.850.670.620.780.560.820.860.940.760.960.950.920.920.940.680.920.86
0.920.870.640.950.380.770.64-0.790.880.770.590.640.440.860.860.940.770.870.910.810.90.860.640.911.0
0.940.920.680.930.420.820.69-0.820.950.780.60.680.480.860.940.940.760.910.980.860.950.90.660.930.94
0.910.710.930.910.450.720.91-0.690.750.390.430.390.730.980.760.770.760.710.70.640.80.880.510.930.78
0.910.970.630.830.420.880.77-0.880.820.70.710.70.40.790.960.870.910.710.950.920.940.940.760.890.85
0.910.950.610.880.380.790.68-0.810.90.770.640.710.390.790.950.910.980.70.950.880.930.90.680.90.9
0.870.930.660.780.130.850.71-0.810.720.80.690.750.50.750.920.810.860.640.920.880.870.90.730.840.8
0.960.930.750.930.510.930.75-0.920.930.770.690.60.470.890.920.90.950.80.940.930.870.950.770.940.89
0.980.940.860.910.410.890.9-0.860.830.630.670.650.630.930.940.860.90.880.940.90.90.950.730.970.85
0.70.740.520.630.360.780.54-0.940.620.620.990.510.150.60.680.640.660.510.760.680.730.770.730.660.62
1.00.890.870.980.410.840.86-0.830.890.660.580.580.640.980.920.910.930.930.890.90.840.940.970.660.91
0.920.860.650.950.390.760.64-0.780.890.750.570.640.460.870.861.00.940.780.850.90.80.890.850.620.91
Click cells to compare fundamentals

Nevro Corp Account Relationship Matchups

Nevro Corp fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets469.6M789.4M574.5M602.4M635.7M461.8M
Other Current Liab54.6M42.2M44.5M45.3M53.7M34.2M
Total Current Liabilities70.6M239.2M82.2M79.2M83.4M71.3M
Total Stockholder Equity216.4M388.5M303.6M323.9M293.1M255.5M
Other Liab1.9M3.3M22.0M2.2M2.5M3.6M
Property Plant And Equipment Net33.3M31.7M38.2M35.7M33.5M19.1M
Net Debt115.4M282.6M132.0M76.8M117.6M85.6M
Retained Earnings(409.8M)(492.8M)(624.2M)(607.2M)(699.4M)(664.4M)
Accounts Payable16.0M23.1M32.0M26.8M22.5M19.3M
Cash65.4M44.6M34.7M120.4M104.2M58.2M
Non Current Assets Total47.6M36.3M43.3M39.5M104.8M110.0M
Non Currrent Assets Other13.3M4.0M4.5M3.2M5.8M4.5M
Other Assets14.3M22.8M5.1M3.8M1.00.95
Cash And Short Term Investments237.8M588.0M362.0M374.4M322.7M289.0M
Net Receivables82.8M77.7M70.5M78.9M79.4M57.9M
Common Stock Shares Outstanding30.8M33.7M34.8M35.5M36.0M26.7M
Short Term Investments172.4M543.4M327.3M254.0M218.5M230.8M
Liabilities And Stockholders Equity469.6M789.4M574.5M602.4M635.7M461.8M
Non Current Liabilities Total182.7M161.8M188.7M199.3M259.2M135.1M
Inventory91.6M83.3M93.5M99.6M118.7M78.7M
Other Current Assets9.8M8.3M5.2M10.0M10.1M6.7M
Other Stockholder Equity626.4M880.7M928.1M934.1M992.8M588.4M
Total Liab253.3M401.0M270.9M278.5M342.6M206.3M
Property Plant And Equipment Gross33.3M31.7M38.2M35.7M69.2M72.6M
Total Current Assets422.1M753.1M531.2M562.9M530.9M432.0M
Accumulated Other Comprehensive Income(313K)598K(364K)(3.1M)(243K)(255.2K)
Property Plant Equipment11.8M13.5M20.7M22.3M25.6M26.9M
Short Long Term Debt Total180.7M327.2M166.7M197.2M221.8M172.5M
Net Tangible Assets216.4M388.5M303.6M323.9M372.5M291.2M
Long Term Debt160.3M141.8M151.3M186.9M211.5M145.9M
Retained Earnings Total Equity(409.8M)(492.8M)(624.2M)(607.2M)(546.5M)(573.8M)
Long Term Debt Total160.3M141.8M151.3M186.9M214.9M136.3M
Capital Surpluse626.4M880.7M928.1M934.1M1.1B686.8M
Non Current Liabilities Other22.4M20.0M37.4M12.5M43.1M45.2M
Net Invested Capital376.7M699.0M454.9M510.7M504.6M524.5M
Net Working Capital351.4M513.9M449.0M483.7M447.5M473.0M

Pair Trading with Nevro Corp

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nevro Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nevro Corp will appreciate offsetting losses from the drop in the long position's value.

Moving against Nevro Stock

  0.51DOCS DoximityPairCorr
  0.5VMD Viemed HealthcarePairCorr
  0.44FOXO FOXO TechnologiesPairCorr
The ability to find closely correlated positions to Nevro Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nevro Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nevro Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nevro Corp to buy it.
The correlation of Nevro Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nevro Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nevro Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nevro Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Nevro Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nevro Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nevro Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nevro Corp Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nevro Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.
You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nevro Corp. If investors know Nevro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nevro Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.87)
Revenue Per Share
11.404
Quarterly Revenue Growth
(0.07)
Return On Assets
(0.09)
Return On Equity
(0.25)
The market value of Nevro Corp is measured differently than its book value, which is the value of Nevro that is recorded on the company's balance sheet. Investors also form their own opinion of Nevro Corp's value that differs from its market value or its book value, called intrinsic value, which is Nevro Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nevro Corp's market value can be influenced by many factors that don't directly affect Nevro Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nevro Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nevro Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nevro Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.